Director, US Value, Access, and Pricing Strategy

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
The Director, U.S. Value, Access, & Pricing Strategy serves as the cell therapy market access lead for the brand supporting our pivotal data and expected near term launch. This role is responsible for the continuous monitoring of potential opportunities and risks to US payer coverage & provider reimbursement and develops appropriate organizational actions to ensure patient access. The successful candidate will lead development of access and reimbursement strategies with insights from the field and is accountable for executing value marketing initiatives through close partnership with the Orca-T Marketing Lead, field Market Access Directors, Sales Leadership, HEOR, Medical, Finance, and Legal to meet brand objectives. S/he will thrive in a rapidly evolving cell therapy market access environment, create clear goals and inspiring plans, develop strong partnerships, and act with agility. This is a remote hybrid role with a preference for proximity to Menlo Park for frequent in-person meetings.

Responsibilities

• Lead the Orca-T U.S. Market Access Strategy while collaborating with the field market access directors to execute the reimbursement and access strategy
• Develop the strategic plan in close coordination with Field Market Access Lead for implementing Orca-T market access strategy through payer and ATC focused tactics within the US market to optimize coverage and reimbursement
• Develop innovative payer and provider value creation tools & approaches
• Accountable for delivering robust value proposition and evidence package to meet US payer & ATC needs and co-train field market access directors on the associated marketing materials through close partnership with all stakeholders
• Working with Medical and HEOR, continuously define evolving Orca-T value in US market, including evaluation of clinical, humanistic and economic benefits relative to standards of care and emerging competitors
• Partner with HEOR in development and execution of plans to identify evidence generation needs through additional studies, publications, messaging and scientific communication
• Contribute to US pricing & contracting life-cycle strategies, evaluation of innovative value-based pricing approaches, and pricing analytics
• Collaborates with cross-functional team to conduct in-depth analyses that drive identification of rich market insights across payers and ATC’s to optimize patient journey and launch
• Conduct primary research to understand payer and ATC needs in the US cell therapy market
• Collect key insights regarding customer experience and access needs
• Contribute to policy/government affairs advocacy strategies to optimize cell therapy access & reimbursement for patients, payers, and providers
• Partner to ensure all activities are following regulatory and legal requirements
• Travel ≤ 20%

Qualifications

• Master’s Degree and 10+ years of experience OR
• Bachelor’s Degree and 12+ years of experience
• Extensive understanding of the transplant clinical landscape and the business of cell therapy
• Excellent strategic thinker, with the ability to formulate, develop and execute strategy based on applied analytical skills
• Proven track record in developing market access strategy/materials & marketing initiatives for oncology products by leveraging market research, data, and analytics in highly complex and competitive markets
• Market Access & Pricing financial experience within US Healthcare System to include buy and bill, inpatient and outpatient hospital economics, governmental reimbursement, and payer/provider economics
• Advanced pricing analytics experience ideal, including knowledge of government pricing mechanics for buy and bill products
• Experience developing value proposition while aligning and contributing to HEOR evidence generation plans to define and deliver value stories to economic decision makers
• Ability to lead and influence cross-functional partners to develop innovativ